Role of peroxisome proliferator-activated receptor γ and its ligands in non-neoplastic and neoplastic human urothelial cells
Role of peroxisome proliferator-activated receptor γ and its ligands in non-neoplastic and neoplastic human urothelial cells
复制标题
DOI:
10.1016/s0002-9440(10)61730-0
复制
发表时间:
2001-08-01
影响因子:
6
通讯作者:
Oyasu, R
中科院分区:
文献类型:
--
作者:
Nakashiro, K;Hayashi, Y;Oyasu, R
Peroxisome proliferator-activated receptor gamma (PPAR-gamma) is a member of the nuclear receptor superfamily of ligand-activated transcription factors and is expressed in several types of tissue. Although PPAR gamma reportedly is expressed in normal urothelium, its function is unknown. We examined the expression of PPAR gamma in. normal urothelium and bladder cancer in an attempt to assess its functional role. Immunohistochemical staining revealed normal urothelium to express PPAR gamma uniformly. All low-grade carcinomas were positive either diffusely or focally, whereas staining was primarily focal or absent in high-grade carcinomas. A nonneoplastic urothelial cell line (1T-1), a low-grade (RT4) carcinoma cell fine, and two high-grade (T24 and 253J) carcinoma cell lines in culture expressed PPAR gamma mRNA and protein. Luciferase assay indicated that PPAR gamma was functional. PPAR gamma ligands (15-deoxy-Delta (12,14)-prostaglandin J(2), troglitazone and pioglitazone) suppressed the growth of nonneoplastic and neoplastic urothelial cells in a dose-dependent manner. However, neoplastic cells were more resistant than were nonneoplastic cells. Failure to express PPAR gamma or ineffective transcriptional activity may be some of the mechanisms responsible for resistance to the inhibitory action of PPAR gamma ligands.